GlaxoSmithKline Pharmaceuticals Limited announced its decision to transfer its rights in relation to the Iodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited, subject to shareholder approval, for an aggregate consideration of Rs 1649 crores. The company also declared its financial results for the quarter ended June 30, 2021. Revenue for the quarter came in…
GlaxoSmithKline plc and Samsung Biologics have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK’s innovative biopharmaceutical therapies. Under the terms of the agreement, Samsung Biologics will provide GSK with additional capacity for large-scale biopharmaceutical product manufacturing. This capacity will be flexible depending on GSK’s future needs and will…
India’s largest FMCG company Hindustan Unilever Limited (HUL), recently announced that it has successfully completed the merger of GlaxoSmithKline Consumer Healthcare Limited (GSKCH) with HUL. This merger was first announced in December 2018 and was subject to obtaining necessary approvals. It is being said that the acquisition is one of the largest deals in the…
India’s fastest growing Contract Development and Manufacturing Organization (CDMOs) Sai Life Sciences recently announced the appointment of Dr. Dean Edney as Senior Vice President and Global Head of Process Research & Development. In a press release, the company said that Edney will split his time between the company’s R&D center in Hyderabad, India and the…
Fast-moving consumer goods major Hindustan Unilever announced an all-equity merger of itself with GlaxoSmithKline Consumer Healthcare Limited (GSK CH India), for a transaction worth Rs 31,700 crore in the country’s largest deal within consumer goods market. The all-equity merger deal includes an exchange ratio of 4.39 HUL shares for each GSK Consumer India share, along with…